secwatch.observer — SEC 8-K summary
======================================

Issuer:     AVANOS MEDICAL, INC. (AVNS)
CIK:        0001606498
Form:       8-K
Filed at:   2023-05-03T23:59:59+00:00
Accession:  0001606498-23-000039
Event type: other
Sentiment:  neutral
Materiality: 0.50
Item codes: 2.02, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Avanos Medical reports Q1 results and holds annual meeting; all proposals approved
--------------------------------------------------------------------------------

- Q1 2023 earnings released May 3, 2023; no financial figures provided in the filing.
- Annual meeting held Apr 27, 2023; 94.23% of shares represented (43,916,111 shares).
- All six director nominees elected; Dr. Julie Shimer received lowest support (35.5M for, 6.2M withheld).
- Delaware auditor ratified (43.5M for, 0.27M against); advisory say-on-pay approved (38.96M for, 2.59M against).
- LTIP amended to increase authorized shares by 1.25M (39.96M for, 1.59M against).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1606498/000160649823000039/0001606498-23-000039-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1606498/000160649823000039/avns-20230427.htm
  HTML page:      https://secwatch.observer/filing/0001606498-23-000039

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer